LUIS GONZAGA
PAZ-ARES RODRÍGUEZ
Profesor titular de universidad
University of Maryland, Baltimore
Baltimore, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Maryland, Baltimore (1)
2012
-
Treatment rationale study design for the MetLung trial: A randomized, double-blind phase III study of onartuzumab (MetMAb) in combination with erlotinib versus erlotinib alone in patients who have received standard chemotherapy for stage IIIB or IV met-positive non-small-cell lung cancer
Clinical Lung Cancer, Vol. 13, Núm. 6, pp. 500-504